| FIIN-3 |
FIIN-3 |
1637735-84-2 |
| RAF709 |
化合物RAF709 |
1628838-42-5 |
| Pimodivir |
VX-787 |
1629869-44-8 |
| CPI-1205 |
CPDB1215 |
1621862-70-1 |
| 1-(4-(5-(5-amino-6-(5-(tert-butyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1H-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one |
AZD-8835 |
1620576-64-8 |
| SEP-0372814 |
SEP-0372814 |
1516895-53-6 |
| GSK-LSD1 |
GSK-LSD1 |
1431368-48-7 |
| KPT-330, (E)-RN |
(E)-3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-N'-(PYRAZIN-2-YL)ACRYLOHYDRAZIDE |
1421923-86-5 |
| UNC 1079 |
1,4-伸苯基双(1,4'-二哌啶-1'-基甲酮) |
1418741-86-2 |
| GSK2879552 |
GSK2879552 |
1401966-69-5 |
| JD-5037 |
JD-5037 |
1392116-14-1 |
| M2698 |
M2698 |
1379545-95-5 |
| CPI-268456 |
CPI-268456 |
1380087-86-4 |
| YH239-EE |
[N/A] |
1364488-67-4 |
| ALK/IGF1R inhibitor |
AZD3463 |
1356962-20-3 |
| Mutant IDH1-IN-1 |
MUTANT IDH1-IN-1 |
1355326-21-4 |
| 7,8-Dihydro-2,3-bis(4-methylphenyl)pyrido[2,3-b]pyrazine-5(6H)-heptanoic acid |
7,8-二氢-2,3-二(4-甲基苯基)吡啶并[2,3-B]吡嗪-5(6H)-庚酸 |
1356331-63-9 |
| Naloxegol Oxalate |
聚乙二醇纳诺醇 |
1354744-91-4 |
| N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide |
化合物GSK503 |
1346572-63-1 |
| 2-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-N-benzyl-5,6,7,8-tetrahydroquinazolin-4-amine |
ML241 |
1346528-06-0 |
